UBS reiterates Buy rating on Darden stock ahead of earnings

UBS reiterated a Buy on Darden Restaurants with a $230 price target and sees the shares trading at ~17x consensus FY2027 EPS; the stock currently trades at a P/E of 20.91 and a $23.1B market cap. UBS expects Olive Garden comps modestly below the 4.4% consensus and LongHorn modestly above the 5.7% consensus; company guidance range includes sales growth of 8.5%-9.3%, blended comps 3.5%-4.3%, and adjusted EPS of $10.50-$10.70 (consensus EPS $10.57). Analysts remain generally constructive (KeyBanc OW $225 PT, Stifel Buy, Mizuho raised PT to $195) but flag near-term risks from weather and elevated beef costs; Darden yields 2.98% and has paid dividends for 32 consecutive years. Management is closing 14 Bahama Breeze locations and converting another 14 over the next 12-18 months, a small but strategic portfolio shift.

Analysis

The strategic pruning and brand reallocation underway in large casual-dining portfolios shifts where incremental capital and marketing dollars land: higher-return steakhouses and scale Italian concepts will absorb incremental traffic and promotional spend, while marginal concepts relinquish leases that become turnkey sites for regional players. That flow both concentrates commodity exposure (more beef going to fewer concepts) and creates a short-run glut of conversion-capable real estate that agile competitors can snap up at below-replacement cost, accelerating share shifts over 6–18 months.

Beef-price volatility remains the single largest input risk, but its transmission to profits is neither instantaneous nor linear — contractual delivery schedules, negotiated supplier terms, and menu engineering allow operators to phase pass-throughs over 2–4 quarters. Near-term catalysts to watch: the next quarterly print (directional guidance), weather-driven comps in key markets, and any sudden shifts in export demand (China/MENA) that can swing cattle futures within weeks; structural reversal requires either a sustained traffic collapse or a sharp drop in wholesale protein costs.

Consensus weakness toward some big casual-names appears to over-index on input-cost risk and under-estimate operating optionality (conversions, delivery-driven ticket lift, targeted menu inflation). That creates a clear alpha opportunity for companies with leaner concept portfolios and flexible real-estate playbooks — the market is pricing a binary outcome when the reality is a multi-quarter margin rebalancing. Watch earnings-guidance language for signals that managements are moving from reactive price defense to proactive mix-shift monetization.

Key Decisions for Investors

• Long EAT (Brinker) equity, 3–6 month horizon: overweight into the next two prints to capture upside from share gains and conversion-led margin improvement. Target 20–30% upside vs current levels; stop-loss at 10% to limit earnings-driven volatility.
• Pair trade — Long EAT / Short TSN (Tyson), 3–6 months: isolates consumer demand and unit-level margin improvement from raw-protein cost exposure. Position sizing 1:1 dollar-neutral; expect outperformance if traffic recovery and mix-shift offset protein inflation — asymmetric upside if beef costs normalize (R/R ~1.5–2x).
• Options play — Buy EAT 3-month calls 10–15% OTM as a tactical positon into upcoming guidance windows: limited premium risk with >3x payoff if guidance is tightened upward or comps beat materially. Size to no more than 2–3% of portfolio to preserve optionality against headline risk.
• Event hedge — If worried about a sudden deflation in protein costs reversing the trade, buy 3–6 month TSN puts or establish a small short in live-cattle futures to protect pair position; treat as insurance and size at <50% of base exposure.